We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RF icon
301
Regions Financial
RF
$26.8B
$33.8M 0.06%
1,817,185
+319,816
+21% +$6.06M
TJX icon
302
TJX Companies
TJX
$178B
$33.7M 0.06%
826,330
-32,892
-4% -$1.3M
LH icon
303
Labcorp
LH
$25.9B
$33.6M 0.06%
241,765
+21,502
+10% +$3.16M
DFS
304
DELISTED
Discover Financial Services
DFS
$33.3M 0.06%
462,505
+28,754
+7% +$2.22M
IP icon
305
International Paper
IP
$22B
$33.2M 0.06%
655,219
+53,978
+9% +$3M
SAP icon
306
SAP
SAP
$238B
$33.1M 0.06%
315,087
+27,571
+10% +$2.98M
VGT icon
307
Vanguard Information Technology ETF
VGT
$149B
$33.1M 0.06%
1,549,024
+105,112
+7% +$2.3M
NTB icon
308
Bank of N.T. Butterfield & Son
NTB
$2.45B
$32.9M 0.06%
733,554
+18,818
+3% +$802K
XPO icon
309
XPO
XPO
$23.7B
$32.6M 0.06%
926,050
-38,924
-4% -$1.3M
SRCL
310
DELISTED
Stericycle Inc
SRCL
$32.5M 0.06%
555,273
+114,721
+26% +$7.77M
WBA
311
DELISTED
Walgreens Boots Alliance
WBA
$32.1M 0.06%
490,249
+3,418
+0.7% +$244K
VB icon
312
Vanguard Morningstar Small-Cap ETF
VB
$82.7B
$31.8M 0.06%
216,439
+26,593
+14% +$3.97M
STLD icon
313
Steel Dynamics
STLD
$37.6B
$31.8M 0.06%
719,073
+110,711
+18% +$5.1M
ASML icon
314
ASML
ASML
$669B
$31.6M 0.06%
159,382
-3,097
-2% -$610K
ENB icon
315
Enbridge
ENB
$112B
$31.6M 0.06%
1,005,164
-101,937
-9% -$3.57M
CMI icon
316
Cummins
CMI
$88.7B
$31.5M 0.06%
194,510
-49,817
-20% -$8.56M
VFC icon
317
VF Corp
VFC
$5.89B
$31.5M 0.06%
450,987
+853
+0.2% +$61.7K
MAR icon
318
Marriott International
MAR
$92.3B
$31.4M 0.06%
230,628
-16,339
-7% -$2.29M
UN
319
DELISTED
Unilever NV New York Registry Shares
UN
$31.2M 0.06%
553,772
-30,582
-5% -$1.68M
LYG icon
320
Lloyds Banking Group
LYG
$91.3B
$31.1M 0.06%
8,347,196
+5,370,303
+180% +$20.8M
ECL icon
321
Ecolab
ECL
$79.9B
$31M 0.06%
226,309
+19,058
+9% +$2.56M
WCN
322
Waste Connections
WCN
$42B
$30.8M 0.06%
429,528
-30,930
-7% -$2.2M
BRK.A icon
323
Berkshire Hathaway Class A
BRK.A
$1.12T
$30.5M 0.05%
102
-1
-1% -$308K
NVO
324
Novo Nordisk
NVO
$209B
$30.4M 0.05%
1,235,208
+104,098
+9% +$2.73M
RSPT icon
325
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.87B
$30.4M 0.05%
2,009,110
+65,790
+3% +$1.01M

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.